Iron management in end-stage renal diseaseFISHBANE, S; MAESAKA, J. K.American journal of kidney diseases. 1997, Vol 29, Num 3, pp 319-333, issn 0272-6386Article

Regulation of renal urate excretion : A critical reviewMAESAKA, J. K; FISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 917-933, issn 0272-6386Article

Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsRUGGIAN, J. C; MAESAKA, J. K; FISHBANE, S et al.American journal of kidney diseases. 1996, Vol 28, Num 3, pp 409-414, issn 0272-6386Article

Is there material hazard to treatment with intravenous iron?FISHBANE, S; MAESAKA, J. K; MITTAL, S. K et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 11, pp 2595-2598, issn 0931-0509Conference Paper

Cerebral salt-wasting syndrome : Does it exist?MAESAKA, J. K; GUPTA, S; FISHBANE, S et al.Nephron. 1999, Vol 82, Num 2, pp 100-109, issn 0028-2766Article

Prevalence of hypertension in a hemodialysis populationMITTAL, S. K; KOWALSKI, E; TRENKLE, J et al.Clinical nephrology. 1999, Vol 51, Num 2, pp 77-82, issn 0301-0430Article

Renal salt wasting without cerebral disease : Diagnostic value of urate determinations in hyponatremiaMAESAKA, J. K; MIYAWAKI, N; PALAIA, T et al.Kidney international. 2007, Vol 71, Num 8, pp 822-826, issn 0085-2538, 5 p.Article

Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patientsFISHBANE, S; YOUN, S; FLASTER, E et al.American journal of kidney diseases. 1996, Vol 27, Num 5, pp 668-672, issn 0272-6386Article

Plasma natriuretic factor(S) in patients with intracranial disease, renal salt wasting and hyperuricosuriaMAESAKA, J. K; VENKATESAN, J; PICCIONE, J. M et al.Life sciences (1973). 1993, Vol 52, Num 23, pp 1875-1882, issn 0024-3205Article

Partial characterization of apoptotic factor in Alzheimer plasmaMAESAKA, J. K; PALAIA, T; CHOWDHURY, S. A et al.American journal of physiology. Renal physiology. 1999, Vol 45, Num 4, pp F521-F527, issn 1931-857XArticle

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patientsFISHBANE, S; GALGANO, C; LANGLEY, R. C et al.Kidney international. 1997, Vol 52, Num 1, pp 217-222, issn 0085-2538Conference Paper

Hyponatremia and hypouricemia : differentiation from SIADHMAESAKA, J. K; BATUMAN, V; YUDD, M et al.Clinical nephrology. 1990, Vol 33, Num 4, pp 174-178, issn 0301-0430Article

Paraneoplastic syndromes of the kidneyMAESAKA, J. K; MITTAL, S. K; FISHBANE, S et al.Seminars in oncology. 1997, Vol 24, Num 3, pp 373-381, issn 0093-7754Article

The safety of intravenous iron dextran in hemodialysis patientsFISHBANE, S; UNGUREANU, V.-D; MAESAKA, J. K et al.American journal of kidney diseases. 1996, Vol 28, Num 4, pp 529-534, issn 0272-6386Article

Effect of time of day of dialysis shift on serum biochemical parameters in patients on chronic hemodialysisMATTANA, J; PATEL, A; WAGNER, J. D et al.American journal of nephrology. 1995, Vol 15, Num 3, pp 208-216, issn 0250-8095Article

Sucralfate on serum lipids and lipoproteins in normal volunteersSCHWENK, M. H; BERK, S. I; MORGAN, D. V et al.Journal of clinical pharmacology. 1994, Vol 34, Num 7, pp 787-792, issn 0091-2700Article

Abnormal urate transport in patients with intracranial diseaseMAESAKA, J. K; VENKATESAN, J; PICCIONE, J. M et al.American journal of kidney diseases. 1992, Vol 19, Num 1, pp 10-15, issn 0272-6386Article